Please enable JS
 
In the spotlight
Specialty Tier Drugs

Help support bills that limit patients’ costs for specialty tier drugs. 87% of stand-alone Medicare Part D Prescription Drug Plans and 98% of Medicare Advantage-Prescription Drug Plans use specialty tiers, and this can be very expensive for those in need of special medicines.

 

IN THE NEWSVIEW ALL

img

Pfizer Website Offers Primer on Biosimilars

Dec 26/

Pfizer offers a patient-friendly explanation of biosimilars – what they are, how they differ from generics, and how they are developed and approved, among other topics on the company’s biosimilars

READ MORE
img

Biosimilars Market Taking Off in the U.S.

Dec 26/

By 2020, the global biosimilars market is expected to top $390 billion and account for up to 28 percent of the global market for pharmaceuticals, due in large part to the loss of patent protection for

READ MORE
img

GHLF’s Analysis of Current Step Therapy Regulations

Dec 26/

In an analysis of step therapy regulations, GHLF looked at every state bill currently related to step therapy and scored them on how strongly they protected patients on a scale from one to 10. You can

READ MORE
Become an Advocate
JOIN US TODAY